Nahdi Medical Company

SASE:4164 Stok Raporu

Piyasa değeri: ر.س15.3b

Nahdi Medical Gelecekteki Büyüme

Future kriter kontrolleri 3/6

Nahdi Medical kazanç ve gelirin sırasıyla yıllık 6.7% ve 5.9% oranında artacağı tahmin edilmektedir. EPS'nin yıllık 6% oranında büyümesi beklenmektedir. Özkaynak kârlılığının 3 yıl içinde 31.7% olacağı tahmin edilmektedir.

Anahtar bilgiler

6.7%

Kazanç büyüme oranı

6.0%

EPS büyüme oranı

Consumer Retailing kazanç büyümesi19.3%
Gelir büyüme oranı5.9%
Gelecekteki özkaynak getirisi31.7%
Analist kapsamı

Good

Son güncelleme13 Nov 2024

Gelecekteki son büyüme güncellemeleri

Nahdi Medical Company Beat Revenue Forecasts By 6.2%: Here's What Analysts Are Forecasting Next

Aug 07
Nahdi Medical Company Beat Revenue Forecasts By 6.2%: Here's What Analysts Are Forecasting Next

Recent updates

Returns On Capital Signal Tricky Times Ahead For Nahdi Medical (TADAWUL:4164)

Oct 18
Returns On Capital Signal Tricky Times Ahead For Nahdi Medical (TADAWUL:4164)

Nahdi Medical Company's (TADAWUL:4164) Share Price Is Matching Sentiment Around Its Earnings

Sep 13
Nahdi Medical Company's (TADAWUL:4164) Share Price Is Matching Sentiment Around Its Earnings

Nahdi Medical Company Beat Revenue Forecasts By 6.2%: Here's What Analysts Are Forecasting Next

Aug 07
Nahdi Medical Company Beat Revenue Forecasts By 6.2%: Here's What Analysts Are Forecasting Next

Nahdi Medical (TADAWUL:4164) Has Announced A Dividend Of SAR2.50

Aug 03
Nahdi Medical (TADAWUL:4164) Has Announced A Dividend Of SAR2.50

Capital Allocation Trends At Nahdi Medical (TADAWUL:4164) Aren't Ideal

Jun 18
Capital Allocation Trends At Nahdi Medical (TADAWUL:4164) Aren't Ideal

There's No Escaping Nahdi Medical Company's (TADAWUL:4164) Muted Earnings

Apr 25
There's No Escaping Nahdi Medical Company's (TADAWUL:4164) Muted Earnings

Nahdi Medical (TADAWUL:4164) Is Paying Out A Dividend Of SAR3.00

Mar 21
Nahdi Medical (TADAWUL:4164) Is Paying Out A Dividend Of SAR3.00

The Returns On Capital At Nahdi Medical (TADAWUL:4164) Don't Inspire Confidence

Jan 07
The Returns On Capital At Nahdi Medical (TADAWUL:4164) Don't Inspire Confidence

Analyst Estimates: Here's What Brokers Think Of Nahdi Medical Company (TADAWUL:4164) After Its First-Quarter Report

Aug 07
Analyst Estimates: Here's What Brokers Think Of Nahdi Medical Company (TADAWUL:4164) After Its First-Quarter Report

Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital

Jul 25
Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital

Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital

Mar 22
Here's What's Concerning About Nahdi Medical's (TADAWUL:4164) Returns On Capital

Nahdi Medical Company's (TADAWUL:4164) Price Is Out Of Tune With Earnings

Dec 13
Nahdi Medical Company's (TADAWUL:4164) Price Is Out Of Tune With Earnings

We Think Nahdi Medical's (TADAWUL:4164) Profit Is Only A Baseline For What They Can Achieve

Aug 20
We Think Nahdi Medical's (TADAWUL:4164) Profit Is Only A Baseline For What They Can Achieve

Are Investors Undervaluing Nahdi Medical Company (TADAWUL:4164) By 27%?

Aug 01
Are Investors Undervaluing Nahdi Medical Company (TADAWUL:4164) By 27%?

Kazanç ve Gelir Büyüme Tahminleri

SASE:4164 - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (SAR Millions )
TarihGelirKazançlarSerbest Nakit AkışıFaaliyetlerden NakitAvg. Analist Sayısı
12/31/202610,4919618691,7395
12/31/20259,8959017621,6556
12/31/20249,4828567831,2772
9/30/20249,2988339521,348N/A
6/30/20249,1078649131,339N/A
3/31/20248,8668818081,218N/A
12/31/20238,7148939841,369N/A
9/30/20238,6388501,3151,647N/A
6/30/20238,6348911,0661,371N/A
3/31/20238,6428951,4351,721N/A
12/31/20228,6168881,3931,668N/A
9/30/20228,4519031,2481,524N/A
6/30/20228,3348971,2771,555N/A
3/31/20228,1658551,1171,391N/A
12/31/20218,0668131,0281,334N/A
9/30/20218,0798361,3291,621N/A
6/30/20218,1736821,4281,721N/A
3/31/20218,3637501,4901,818N/A
12/31/20208,6428491,2661,586N/A
12/31/20197,8256921,1141,348N/A
12/31/20187,350611797980N/A
12/31/20177,056721N/A911N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: 4164 'nin tahmini kazanç büyümesi (yıllık 6.7% ) tasarruf oranının ( 14.7% ) altındadır.

Kazançlar ve Piyasa: 4164 şirketinin kazançlarının (yıllık 6.7% ) SA pazarından (yıllık 6.5% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Kazançları: 4164 şirketinin kazançlarının artması bekleniyor, ancak önemli ölçüde.

Gelir ve Pazar: 4164 şirketinin gelirinin (yıllık 5.9% ) SA pazarından (yıllık -0.2% ) daha hızlı büyümesi öngörülüyor.

Yüksek Büyüme Geliri: 4164 şirketinin gelirinin (yıllık 5.9% ) yıllık 20% oranından daha yavaş büyümesi öngörülüyor.


Hisse Başına Kazanç Büyüme Tahminleri


Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: 4164 'in Özsermaye Getirisi'nin 3 yıl içinde yüksek olması tahmin ediliyor ( 31.7 %)


Büyüyen şirketleri keşfedin